4.8 Editorial Material

Plasmacytoid dendritic cells lead the charge against tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

Barbara Drobits et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Oncology

Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod

Elizabeth C. Smyth et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Immunology

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

Mercedes B. Fuertes et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Multidisciplinary Sciences

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin-Zhi Qian et al.

NATURE (2011)

Review Oncology

Toll-Like Receptor Agonists Are They Good Adjuvants?

Sacha Gnjatic et al.

CANCER JOURNAL (2010)

Review Immunology

Trafficking properties of plasmacytoid dendritic cells in health and disease

Silvano Sozzani et al.

TRENDS IN IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α

Andrew W. Hardy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Immunology

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells

Georg Stary et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Multidisciplinary Sciences

Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function

GY Peng et al.

SCIENCE (2005)

Article Dermatology

Topical imiquimod in the treatment of metastatic melanoma to skin

IH Wolf et al.

ARCHIVES OF DERMATOLOGY (2003)

Article Dermatology

Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures

T Meyer et al.

BRITISH JOURNAL OF DERMATOLOGY (2003)

Review Dermatology

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

MA Stanley

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2002)